• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.97% Nasdaq Down0.61%

    Lexicon Pharmaceuticals, Inc. (LXRX)

    -NasdaqGS
    13.56 Up 5.12(60.71%) 1:47PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 1,792   21,482   419   676  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,792   21,482   419   676  
    Operating Expenses
    Research Development20,865  20,031  24,108  21,187  
    Selling General and Administrative7,454  4,898  3,545  5,600  
    Non Recurring -   -  13,102   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (26,527) (3,447) (40,336) (26,111)
    Income from Continuing Operations
    Total Other Income/Expenses Net153  1,336  287  538  
    Earnings Before Interest And Taxes(26,374)(2,111)(40,049)(25,573)
    Interest Expense1,702  892  449  455  
    Income Before Tax(28,076)(3,003)(40,498)(26,028)
    Income Tax Expense -  (70) -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(28,076)(2,933)(40,498)(26,028)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (28,076) (2,933) (40,498) (26,028)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (28,076) (2,933) (40,498) (26,028)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.